Genentech · 23 hours ago
2026 Summer Intern - Proteomic and Genomic Technologies
South San Francisco, CA
Internship
Onsite
Intern
$40/hr - $46/hr
Start in 2026 SpringGenentech is a leading biotechnology company seeking a highly motivated research intern for their Proteomic and Genomic Technologies department. The intern will drive research in single-cell technology, evaluate methods for long-read sequencing, and develop bioinformatic tools for data analysis.
BiotechnologyLife ScienceManufacturing
Responsibilities
Drive cutting-edge research in the single-cell technology field
Evaluate and adapt various single-cell methods for compatibility with long-read sequencing methods (Oxford Nanopore Technologies, Pacific Biosciences)
Gain familiarity with and develop bioinformatic tools/pipelines for single-cell long-read RNA sequencing data analysis
Apply critical thinking and problem-solving to achieve project goals
Contribute to Genentech’s culture of scientific curiosity and discovery via cross-department presentations
Qualification
Required
Must be pursuing a Master's Degree (enrolled student)
Must have attained a Master's Degree
Must be pursuing a PhD (enrolled student)
Must have attained a PhD
Required Majors: Molecular Biology, Computational Biology, Biomedical Engineering, Biochemistry, Biological Sciences or a related field
Experience with molecular biology techniques such as PCR, gel electrophoresis, DNA/RNA extraction
Familiarity with sequencing technology
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Prior knowledge of computational biology is preferred
Prior knowledge of single cell technologies/methods is preferred
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
Founded in 1976
10001+ employees
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Ashley Magargee
Chief Executive Officer
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
Recent News
2026-01-07
Company data provided by crunchbase